Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Augurex

Augurex
PRIVATE STATUS
1-10 EMPLOYEES
Early Stage VC LATEST DEAL TYPE
3 INVESTORS
Description

Owner and operator of a biotechnology company intended to focus on developing bio-marker blood tests. The company's biotechnology services includes developing bio-markers to diagnose patients by predicting which treatment will personally offer maximum therapeutic benefit while minimizing side effects, enabling patients to the benefit of earlier detection of diseases.

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Therapeutic Devices
Primary Office
  • 887 Great Northern Way
  • Suite 125-1
  • Vancouver, British Columbia V5T 4T5
  • Canada

+1 (604) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Augurex’s full profile, request a free trial.

Augurex Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Early Stage VC 25-Jan-2017 00000 Completed Startup
4. Angel (individual) 01-Feb-2011 000.00 00000 Completed Startup
3. Angel (individual) 01-May-2009 000.00 000.00 Completed Startup
2. Angel (individual) 01-Nov-2007 $52.8K $52.8K Completed Startup
1. Grant 01-Jan-2007 $52.7K Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Augurex Competitors (8)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Adverum Biotechnologies Formerly VC-backed Menlo Park, CA 00 00000 00000000000 00000
000000000 Private Equity-Backed Zürich, Switzerland 000.00 000000000000
000000 00000000000 Formerly VC-backed Bedford, MA 000 00000 00000000000 00000
00000000 Venture Capital-Backed Carrollton, TX 00 000.00 00 000000 000.00
000000000 00000000 Formerly VC-backed Alpharetta, GA 00 00000 00000000000 00000
To view this company’s complete list of competitors, request access »

Augurex Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Genome British Columbia Not-For-Profit Venture Capital Minority 000 0000 000000 0
WUTIF Capital Angel Group Minority 000 0000 000000 0
New Ventures BC Accelerator/Incubator 000 0000 000000 0

Augurex Executive Team (2)

Name Title Board
Seat
Contact
Info
Norma Biln Co-Founder & Chief Executive Officer
Anthony Marotta Ph.D Co-Founder & CSO

Augurex Board Members (1)

Name Representing Role Since Contact
Info
Natalie Dakers Self Board Member 000 0000